ReviewFrontiers in immunology2024

Spesolimab for generalized pustular psoriasis: a review of two key clinical trials supporting initial US regulatory approval.

Eran C Gwillim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.